Literature DB >> 15984686

A Monte Carlo derived TG-51 equivalent calibration for helical tomotherapy.

S D Thomas1, M Mackenzie, D W O Rogers, B G Fallone.   

Abstract

Helical tomotherapy (HT) requires a method of accurately determining the absorbed dose under reference conditions. In the AAPM's TG-51 external beam dosimetry protocol, the quality conversion factor, kQ, is presented as a function of the photon component of the percentage depth-dose at 10 cm depth, %dd(10)x, measured under the reference conditions of a 10 x 10 cm2 field size and a source-to-surface distance (SSD) of 100 cm. The value of %dd(10)x from HT cannot be used for the determination of kQ because the design of the HT does not meet the following TG-51 reference conditions: (i) the field size and the practical SSD required by TG-51 are not obtainable and (ii) the absence of the flattening filter changes the beam quality thus affecting some components of kQ. The stopping power ratio is not affected because of its direct relationship to %dd(10)x. We derive a relationship for the Exradin A1SL ion chamber converting the %dd(10)x measured under HT "reference conditions" of SSD=85 cm and a 5 x 10 cm2 field-size [%dd(10)x[HT Ref]], to the dosimetric equivalent value under for TG-51 reference conditions [%dd(10)x[HT TG-51]] for HT. This allows the determination of kQ under the HT reference conditions. The conversion results in changes of 0.1% in the value of kQ for our particular unit. The conversion relationship should also apply to other ion chambers with possible errors on the order of 0.1%.

Mesh:

Year:  2005        PMID: 15984686     DOI: 10.1118/1.1897084

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  3 in total

1.  Design and implementation of a "cheese" phantom-based Tomotherapy TLD dose intercomparison.

Authors:  Hans Schiefer; Konrad Buchauer; Simon Heinze; Guido Henke; Ludwig Plasswilm
Journal:  Strahlenther Onkol       Date:  2015-06-19       Impact factor: 3.621

2.  Helical tomotherapy in head and neck cancer: a European single-center experience.

Authors:  Dirk Van Gestel; Danielle Van den Weyngaert; Geert De Kerf; Bie De Ost; Olivier Vanderveken; Carl Van Laer; Pol Specenier; Yasmyne Geussens; Kristien Wouters; Els Meulemans; Kin Jip Cheung; Vincent Grégoire; Jan B Vermorken
Journal:  Oncologist       Date:  2015-02-11

3.  Implementation and Challenges of International Atomic Energy Agency/American Association of Physicists in Medicine TRS 483 Formalism for Field Output Factors and Involved Uncertainties Determination in Small Fields for TomoTherapy.

Authors:  Rajesh Kinhikar; Suryakant Kaushik; Chandrashekhar Tambe; Sudarshan Kadam; Shrikant Kale; Rituraj Upreti
Journal:  J Med Phys       Date:  2021-09-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.